Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 116446412 | 11644641 | 2 | F | 20150524 | 20160927 | 20151020 | 20160929 | EXP | PL-ASTRAZENECA-2015SE51792 | ASTRAZENECA | 23558.00 | DY | M | Y | 0.00000 | 20160930 | MD | PL | PL |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 116446412 | 11644641 | 1 | PS | OLAPARIB | OLAPARIB | 1 | Oral | Y | U | 0 | TABLET | ||||||||
| 116446412 | 11644641 | 2 | SS | OLAPARIB | OLAPARIB | 1 | Oral | Y | U | 0 | TABLET | ||||||||
| 116446412 | 11644641 | 3 | SS | ABIRATERONE | ABIRATERONE | 1 | Oral | Y | U | 0 | 1000 | MG | TABLET | QD | |||||
| 116446412 | 11644641 | 4 | SS | ABIRATERONE | ABIRATERONE | 1 | Oral | Y | U | 0 | 1000 | MG | TABLET | QD | |||||
| 116446412 | 11644641 | 5 | SS | PREDNISONE. | PREDNISONE | 1 | Oral | 190 | MG | 0 | 5 | MG | TABLET | BID | |||||
| 116446412 | 11644641 | 6 | C | ASPIRIN. | ASPIRIN | 1 | Oral | 0 | 75 | MG | QD | ||||||||
| 116446412 | 11644641 | 7 | C | CANDESARTANUM CILEXETILUM | 2 | Oral | 0 | 32 | MG | QD | |||||||||
| 116446412 | 11644641 | 8 | C | FENOFIBRATUM | 2 | Oral | 0 | 215 | MG | QD | |||||||||
| 116446412 | 11644641 | 9 | C | METFORMINI HYDROCHLORIDUM | 2 | Oral | 0 | 250 | MG | BID | |||||||||
| 116446412 | 11644641 | 10 | C | LERCANIDIPINI HYDROCHLORIDUM | 2 | Oral | 0 | 10 | MG | QD | |||||||||
| 116446412 | 11644641 | 11 | C | TORASEMIDUM | 2 | Oral | 0 | 5 | MG | QD | |||||||||
| 116446412 | 11644641 | 12 | C | BISOPROLOLI FUMARAS | 2 | Oral | 0 | 5 | MG | QD | |||||||||
| 116446412 | 11644641 | 13 | C | LEVOTHYROXINUM NATRICUM | 2 | Oral | 0 | 150 | MG | QD | |||||||||
| 116446412 | 11644641 | 14 | C | VITRUM CALCIUM | 2 | Oral | 0 | 1250 | MG | QD | |||||||||
| 116446412 | 11644641 | 15 | C | KATELIN SR | 2 | Oral | 2 CAPSULES DAILY | 0 | CAPSULE | ||||||||||
| 116446412 | 11644641 | 16 | C | ZOLEDRONIC ACID ACTAVIS | ZOLEDRONIC ACID | 1 | Intravenous (not otherwise specified) | 0 | 4 | MG | /month | ||||||||
| 116446412 | 11644641 | 17 | C | ZOLEDRONIC ACID ACTAVIS | ZOLEDRONIC ACID | 1 | Intravenous (not otherwise specified) | 0 | 4 | MG | /month |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 116446412 | 11644641 | 1 | Prostate cancer metastatic |
| 116446412 | 11644641 | 2 | Prostate cancer metastatic |
| 116446412 | 11644641 | 3 | Prostate cancer metastatic |
| 116446412 | 11644641 | 4 | Prostate cancer metastatic |
| 116446412 | 11644641 | 5 | Prostate cancer metastatic |
| 116446412 | 11644641 | 6 | Bone pain |
| 116446412 | 11644641 | 7 | Hypertension |
| 116446412 | 11644641 | 8 | Hyperlipidaemia |
| 116446412 | 11644641 | 9 | Diabetes mellitus |
| 116446412 | 11644641 | 10 | Hypertension |
| 116446412 | 11644641 | 11 | Hypertension |
| 116446412 | 11644641 | 12 | Hypertension |
| 116446412 | 11644641 | 13 | Hypothyroidism |
| 116446412 | 11644641 | 14 | Mineral supplementation |
| 116446412 | 11644641 | 15 | Mineral supplementation |
| 116446412 | 11644641 | 16 | Metastases to bone |
| 116446412 | 11644641 | 17 | Bone pain |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 116446412 | 11644641 | HO |
| 116446412 | 11644641 | LT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 116446412 | 11644641 | Febrile neutropenia |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 116446412 | 11644641 | 1 | 20150506 | 20150525 | 0 | |
| 116446412 | 11644641 | 2 | 20150610 | 0 | ||
| 116446412 | 11644641 | 3 | 20150506 | 20150525 | 0 | |
| 116446412 | 11644641 | 4 | 20150601 | 0 | ||
| 116446412 | 11644641 | 5 | 20150506 | 0 |